Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

A prospective, controlled study of the botanical compound mixture LCS101 for chemotherapy-induced hematological complications in breast cancer.

Yaal-Hahoshen N, Maimon Y, Siegelmann-Danieli N, Lev-Ari S, Ron IG, Sperber F, Samuels N, Shoham J, Merimsky O.

Oncologist. 2011;16(9):1197-202. doi: 10.1634/theoncologist.2011-0150. Epub 2011 Jun 28.

2.

Inflammatory mediators in breast cancer: coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition.

Soria G, Ofri-Shahak M, Haas I, Yaal-Hahoshen N, Leider-Trejo L, Leibovich-Rivkin T, Weitzenfeld P, Meshel T, Shabtai E, Gutman M, Ben-Baruch A.

BMC Cancer. 2011 Apr 12;11:130. doi: 10.1186/1471-2407-11-130.

3.

Effect of Chinese herbal therapy on breast cancer adenocarcinoma cell lines.

Maimon Y, Karaush V, Yaal-Hahoshen N, Ben-Yosef R, Ron I, Vexler A, Lev-Ari S.

J Int Med Res. 2010;38(6):2033-9.

PMID:
21227007
4.

Invasive breast cancer treated with taxol and epirubicin neo-adjuvant chemotherapy: the role in the outcome of the "crosstalk" between Erb receptors and p53.

Sarid D, Ron IG, Shoshan L, Barnea I, Shina S, Baratz M, Greenberg J, Merimsky O, Ben-Yosef R, Lev-Ari S, Keidar Y, Yaal-Hahoshen N.

Anticancer Res. 2008 Sep-Oct;28(5B):3147-52.

5.

Concomitant expression of the chemokines RANTES and MCP-1 in human breast cancer: a basis for tumor-promoting interactions.

Soria G, Yaal-Hahoshen N, Azenshtein E, Shina S, Leider-Trejo L, Ryvo L, Cohen-Hillel E, Shtabsky A, Ehrlich M, Meshel T, Keydar I, Ben-Baruch A.

Cytokine. 2008 Oct;44(1):191-200. doi: 10.1016/j.cyto.2008.08.002. Epub 2008 Sep 13.

PMID:
18790652
6.

Fulvestrant in heavily pretreated metastatic breast cancer: is it still effective as a very advanced line of treatment?

Safra T, Greenberg J, Ron IG, Ben-Yosef R, Inbar M, Sarid D, Yaal-Hahoshen N.

Isr Med Assoc J. 2008 May;10(5):339-43.

7.

Human endogenous retrovirus (HERV-K) reverse transcriptase as a breast cancer prognostic marker.

Golan M, Hizi A, Resau JH, Yaal-Hahoshen N, Reichman H, Keydar I, Tsarfaty I.

Neoplasia. 2008 Jun;10(6):521-33.

8.

Association between standard clinical and pathologic characteristics and the 21-gene recurrence score in breast cancer patients: a population-based study.

Wolf I, Ben-Baruch N, Shapira-Frommer R, Rizel S, Goldberg H, Yaal-Hahoshen N, Klein B, Geffen DB, Kaufman B.

Cancer. 2008 Feb 15;112(4):731-6.

9.

Dead Sea products.

Ben-Yosef R, Yaal-Hahoshen N.

Isr Med Assoc J. 2007 Oct;9(10):765. No abstract available.

10.

Focal asymmetric breast density: mammographic, sonographic and pathological correlation in 97 lesions--a call to restrain biopsies.

Sperber F, Metser U, Gat A, Shalmon A, Yaal-Hahoshen N.

Isr Med Assoc J. 2007 Oct;9(10):720-3.

11.

Nuclear and cytoplasmic expression of ErbB-4 in prostate cancer.

Ben-Yosef R, Sarid D, Vexler A, Lidawi G, Inbar M, Marmor S, Starr A, Yaal Hahoshen N.

Int J Biol Markers. 2007 Jul-Sep;22(3):181-5.

PMID:
17922460
12.

Neoadjuvant treatment with paclitaxel and epirubicin in invasive breast cancer: a phase II study.

Sarid D, Ron IG, Sperber F, Stadler Y, Kahan P, Kovner F, Ben-Yosef R, Marmor S, Grinberg Y, Maimon N, Weinstein J, Yaal-Hahoshen N.

Clin Drug Investig. 2006;26(12):691-701.

PMID:
17274676
13.
14.

Decreased prevalence of asymptomatic choroidal metastasis in disseminated breast and lung cancer: argument against screening.

Barak A, Neudorfer M, Heilweil G, Merimsky O, Lowenstein A, Inbar M, Yaal-Hahoshen N.

Br J Ophthalmol. 2007 Jan;91(1):74-5. Epub 2006 Aug 30.

15.

The chemokine CCL5 as a potential prognostic factor predicting disease progression in stage II breast cancer patients.

Yaal-Hahoshen N, Shina S, Leider-Trejo L, Barnea I, Shabtai EL, Azenshtein E, Greenberg I, Keydar I, Ben-Baruch A.

Clin Cancer Res. 2006 Aug 1;12(15):4474-80. Review.

16.

Herceptin (trastuzumab): adjuvant and neoadjuvant trials.

Yaal-Hahoshen N, Safra T.

Isr Med Assoc J. 2006 Jun;8(6):416-21. Review. No abstract available.

17.

Preoperative clinical, mammographic and sonographic assessment of neoadjuvant chemotherapy response in breast cancer.

Sperber F, Weinstein Y, Sarid D, Ben Yosef R, Shalmon A, Yaal-Hahoshen N.

Isr Med Assoc J. 2006 May;8(5):342-6.

Supplemental Content

Loading ...
Support Center